UniProt ID | NNRD_HUMAN | |
---|---|---|
UniProt AC | Q8IW45 | |
Protein Name | ATP-dependent (S)-NAD(P)H-hydrate dehydratase {ECO:0000255|HAMAP-Rule:MF_03157} | |
Gene Name | NAXD {ECO:0000312|HGNC:HGNC:25576} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 347 | |
Subcellular Localization | Mitochondrion . | |
Protein Description | Catalyzes the dehydration of the S-form of NAD(P)HX at the expense of ATP, which is converted to ADP. Together with NAD(P)HX epimerase, which catalyzes the epimerization of the S- and R-forms, the enzyme allows the repair of both epimers of NAD(P)HX, a damaged form of NAD(P)H that is a result of enzymatic or heat-dependent hydration.. | |
Protein Sequence | MVTRAGAGTAVAGAVVVALLSAALALYGPPLDAVLERAFSLRKAHSIKDMENTLQLVRNIIPPLSSTKHKGQDGRIGVVGGCQEYTGAPYFAAISALKVGADLSHVFCASAAAPVIKAYSPELIVHPVLDSPNAVHEVEKWLPRLHALVVGPGLGRDDALLRNVQGILEVSKARDIPVVIDADGLWLVAQQPALIHGYRKAVLTPNHVEFSRLYDAVLRGPMDSDDSHGSVLRLSQALGNVTVVQKGERDILSNGQQVLVCSQEGSSRRCGGQGDLLSGSLGVLVHWALLAGPQKTNGSSPLLVAAFGACSLTRQCNHQAFQKHGRSTTTSDMIAEVGAAFSKLFET | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
46 | Phosphorylation | FSLRKAHSIKDMENT HHHHHHCCCCCHHHH | 35.87 | 23312004 | |
65 | Phosphorylation | RNIIPPLSSTKHKGQ HHHCCCCCCCCCCCC | 41.56 | - | |
67 | Phosphorylation | IIPPLSSTKHKGQDG HCCCCCCCCCCCCCC | 33.52 | - | |
68 | Ubiquitination | IPPLSSTKHKGQDGR CCCCCCCCCCCCCCC | 45.31 | - | |
85 | Phosphorylation | VVGGCQEYTGAPYFA EECCCCCCCCCCCHH | 5.65 | 27273156 | |
86 | Phosphorylation | VGGCQEYTGAPYFAA ECCCCCCCCCCCHHH | 26.56 | 27259358 | |
90 | Phosphorylation | QEYTGAPYFAAISAL CCCCCCCCHHHHHHH | 12.81 | 26356563 | |
115 (in isoform 3) | Ubiquitination | - | 6.34 | 21906983 | |
140 | Acetylation | NAVHEVEKWLPRLHA CHHHHHHHHHHHCCE | 60.24 | 25038526 | |
171 | Phosphorylation | VQGILEVSKARDIPV HHHHHHHHCCCCCCE | 15.95 | 22777824 | |
172 | Ubiquitination | QGILEVSKARDIPVV HHHHHHHCCCCCCEE | 53.25 | - | |
172 (in isoform 2) | Ubiquitination | - | 53.25 | - | |
200 | Ubiquitination | ALIHGYRKAVLTPNH CCCCCCHHCCCCCCC | 34.07 | - | |
200 (in isoform 2) | Ubiquitination | - | 34.07 | - | |
222 | Sulfoxidation | DAVLRGPMDSDDSHG HHHHCCCCCCCCCCH | 9.55 | 21406390 | |
224 | Phosphorylation | VLRGPMDSDDSHGSV HHCCCCCCCCCCHHH | 36.75 | 28857561 | |
227 | Phosphorylation | GPMDSDDSHGSVLRL CCCCCCCCCHHHHHH | 34.44 | 28258704 | |
230 | Phosphorylation | DSDDSHGSVLRLSQA CCCCCCHHHHHHHHH | 16.74 | 28258704 | |
240 | N-linked_Glycosylation | RLSQALGNVTVVQKG HHHHHHCCEEEEECC | 27.43 | 19159218 | |
246 | Ubiquitination | GNVTVVQKGERDILS CCEEEEECCCEECCC | 51.64 | 2190698 | |
246 (in isoform 2) | Ubiquitination | - | 51.64 | 21906983 | |
246 (in isoform 1) | Ubiquitination | - | 51.64 | 21906983 | |
297 | N-linked_Glycosylation | LAGPQKTNGSSPLLV HHCCCCCCCCCCHHH | 56.22 | UniProtKB CARBOHYD | |
306 (in isoform 2) | Phosphorylation | - | 8.91 | - | |
323 (in isoform 2) | Phosphorylation | - | 41.39 | - | |
331 | Phosphorylation | HGRSTTTSDMIAEVG HCCCCCHHHHHHHHH | 24.08 | 30576142 | |
342 | Phosphorylation | AEVGAAFSKLFET-- HHHHHHHHHHHCC-- | 24.59 | 30576142 | |
347 | Phosphorylation | AFSKLFET------- HHHHHHCC------- | 36.25 | 30576142 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NNRD_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NNRD_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NNRD_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
KR107_HUMAN | KRTAP10-7 | physical | 25416956 | |
KR109_HUMAN | KRTAP10-9 | physical | 25416956 | |
KR108_HUMAN | KRTAP10-8 | physical | 25416956 | |
KR103_HUMAN | KRTAP10-3 | physical | 25416956 | |
NT2NL_HUMAN | NOTCH2NL | physical | 25416956 | |
GRHPR_HUMAN | GRHPR | physical | 26344197 | |
SIAS_HUMAN | NANS | physical | 26344197 | |
PRDX2_HUMAN | PRDX2 | physical | 26344197 | |
SGTA_HUMAN | SGTA | physical | 21516116 | |
PPT2_HUMAN | PPT2 | physical | 28514442 | |
KMCP1_HUMAN | SLC25A30 | physical | 28514442 | |
MKLN1_HUMAN | MKLN1 | physical | 28514442 | |
NEUFC_HUMAN | CYB5D2 | physical | 28514442 | |
1A02_HUMAN | HLA-A | physical | 28514442 | |
1A03_HUMAN | HLA-A | physical | 28514442 | |
1A01_HUMAN | HLA-A | physical | 28514442 | |
1A26_HUMAN | HLA-A | physical | 28514442 | |
ERD23_HUMAN | KDELR3 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-240, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-85, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-85, AND MASSSPECTROMETRY. |